Recent Finacing
Recent Raise
OS Therapies is a clinical-stage biopharmaceutical company in Cambridge, Maryland developing a Listeria-based OST-HER2 cancer vaccine to prevent osteosarcoma metastasis and a preclinical OST-TDC drug-conjugate platform for solid tumors.